Pracinostat for AML update: follow-up analysis and Phase III trial
Ibrutinib in combination with rituximab – the future of treating FL
Results of the ASPIRE trial for MM: the addition of carfilzomib
Safety profile of anti-CD19 CAR T-cell therapy axicabtagene ciloleucel
How can doctors discuss CLL treatment options with patients?